SNHG19
gene geneOn this page
Also known as SNORD60HG
Summary
SNHG19 (small nucleolar RNA host gene 19, HGNC:49574) is a long non-coding RNA gene on chromosome 16p13.3.
Predicted to be involved in RNA processing. Predicted to be located in nucleolus.
Source: NCBI Gene 100507303 — RefSeq curated summary.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:49574 |
| Approved symbol | SNHG19 |
| Name | small nucleolar RNA host gene 19 |
| Location | 16p13.3 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | SNORD60HG |
| Ensembl gene | ENSG00000260260 |
| Ensembl biotype | lncRNA |
| Entrez | 100507303 |
| RNAcentral | URS00008E39F5 — lncRNA, 357 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 4 lncRNA
ENST00000563192, ENST00000686899, ENST00000720507, ENST00000720508
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000563192 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00004039293 | 2155143 | 2155427 |
| ENSE00004039294 | 2154790 | 2154922 |
Expression profiles
Bgee: expression breadth ubiquitous, 136 present calls, max score 99.03.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 17.3797 / max 342.6100, expressed in 1749 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 155903 | 17.3797 | 1749 |
Top tissues by expression
137 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| thymus | UBERON:0002370 | 99.03 | gold quality |
| pituitary gland | UBERON:0000007 | 98.81 | gold quality |
| adenohypophysis | UBERON:0002196 | 98.73 | gold quality |
| left ovary | UBERON:0002119 | 98.68 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 98.46 | gold quality |
| right uterine tube | UBERON:0001302 | 98.44 | gold quality |
| right ovary | UBERON:0002118 | 97.95 | gold quality |
| ovary | UBERON:0000992 | 97.94 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 97.92 | gold quality |
| body of pancreas | UBERON:0001150 | 97.87 | gold quality |
| endocervix | UBERON:0000458 | 97.69 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 97.52 | gold quality |
| thyroid gland | UBERON:0002046 | 97.51 | gold quality |
| minor salivary gland | UBERON:0001830 | 97.37 | gold quality |
| ectocervix | UBERON:0012249 | 97.36 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 97.34 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 96.93 | gold quality |
| prostate gland | UBERON:0002367 | 96.80 | gold quality |
| skin of abdomen | UBERON:0001416 | 96.79 | gold quality |
| vagina | UBERON:0000996 | 96.66 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 96.66 | gold quality |
| skin of leg | UBERON:0001511 | 96.62 | gold quality |
| body of uterus | UBERON:0009853 | 96.45 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 96.41 | gold quality |
| zone of skin | UBERON:0000014 | 96.37 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 96.30 | gold quality |
| left uterine tube | UBERON:0001303 | 96.27 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 96.27 | gold quality |
| cerebellum | UBERON:0002037 | 96.25 | gold quality |
| cerebellar cortex | UBERON:0002129 | 96.24 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 12.01 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.